STANISLAUS SURGICAL — History
CCN 050726 | 3-year financial timeline | COVID resilience: 25/100
🛡️ Public data only — no PHI permitted on this instance.
$25M
Latest Revenue (FY2022)
-6.0%
Revenue CAGR (3yr)
-18.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $28M | $27M | $25M | -7.7% | -6.0% |
| Operating Expenses | $30M | $28M | $29M | +3.8% | -1.3% |
| Operating Margin | -7.8% | -5.6% | -18.8% | -234.5% | +0.0% |
| Net Income | $-2M | $-2M | $-5M | -208.7% | +0.0% |
| Licensed Beds | 23 | 23 | 23 | +0.0% | +0.0% |
| Total Patient Days | 458 | 353 | 279 | -21.0% | -22.0% |
| Medicare Day % | 60% | 64% | 53% | -16.8% | -6.2% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 25/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -11.7% ($28M → $25M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-6.0%
This Hospital
+7.6%
State Avg
Latest Margin
-18.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $23M | -24.3% |
| FY2024 (proj) | $21M | -29.7% |
| FY2025 (proj) | $20M | -35.2% |